[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Edge Higher Late Afternoon",
    "summary": "Health care stocks edged up late Thursday afternoon, with the NYSE Health Care Index up 0.1% and the",
    "url": "https://finnhub.io/api/news?id=5bb28179f863745281de0846e5e5b9ff9595331820d9c01c5b1c748860070a59",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735246407,
      "headline": "Sector Update: Health Care Stocks Edge Higher Late Afternoon",
      "id": 132169178,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Health care stocks edged up late Thursday afternoon, with the NYSE Health Care Index up 0.1% and the",
      "url": "https://finnhub.io/api/news?id=5bb28179f863745281de0846e5e5b9ff9595331820d9c01c5b1c748860070a59"
    }
  },
  {
    "ts": null,
    "headline": "US FDA proposes standardized testing to detect asbestos in talc products",
    "summary": "Asbestos, a known human carcinogen, can be injurious to consumers if found in talc-containing cosmetic products as there is no established \"safe level\" threshold for exposure to the substance.  If finalized, the rule can help protect consumers from harmful exposure to asbestos, leading to fewer illnesses such as lung and ovarian cancers, the health regulator said.  Johnson & Johnson is facing lawsuits from more than 62,000 claimants, who have alleged that the company's baby powder and other talc products were contaminated with asbestos and caused ovarian and other cancers.",
    "url": "https://finnhub.io/api/news?id=d3721fa004af887325853933dab2807afad1fa0d002f380dd3a47d6c96279b43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735227728,
      "headline": "US FDA proposes standardized testing to detect asbestos in talc products",
      "id": 132169179,
      "image": "https://media.zenfs.com/en/reuters.com/ca21d1bd6188443157199251374bbf44",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Asbestos, a known human carcinogen, can be injurious to consumers if found in talc-containing cosmetic products as there is no established \"safe level\" threshold for exposure to the substance.  If finalized, the rule can help protect consumers from harmful exposure to asbestos, leading to fewer illnesses such as lung and ovarian cancers, the health regulator said.  Johnson & Johnson is facing lawsuits from more than 62,000 claimants, who have alleged that the company's baby powder and other talc products were contaminated with asbestos and caused ovarian and other cancers.",
      "url": "https://finnhub.io/api/news?id=d3721fa004af887325853933dab2807afad1fa0d002f380dd3a47d6c96279b43"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=b9b47ffba395c8b352f2923d024393c0d0b064092066b5525dcd0f61edeb90d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735221619,
      "headline": "Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know",
      "id": 132169180,
      "image": "https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=b9b47ffba395c8b352f2923d024393c0d0b064092066b5525dcd0f61edeb90d7"
    }
  },
  {
    "ts": null,
    "headline": "How To Build A Strategically Balanced $50,000 Dividend Portfolio To Be Well-Positioned For 2025",
    "summary": "Learn how to build a $50,000 dividend portfolio to position yourself well for 2025 with a focus on dividend income, growth, and diversification.",
    "url": "https://finnhub.io/api/news?id=9d183864ed70a18fc1686cc585a273143ae890c1b533464bb2dfd293fc385a66",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735221600,
      "headline": "How To Build A Strategically Balanced $50,000 Dividend Portfolio To Be Well-Positioned For 2025",
      "id": 132166149,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1249796169/image_1249796169.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Learn how to build a $50,000 dividend portfolio to position yourself well for 2025 with a focus on dividend income, growth, and diversification.",
      "url": "https://finnhub.io/api/news?id=9d183864ed70a18fc1686cc585a273143ae890c1b533464bb2dfd293fc385a66"
    }
  },
  {
    "ts": null,
    "headline": "The Smartest Dividend Stocks to Buy With $1,000 Right Now",
    "summary": "Here are three dividend stocks to consider for your long-term portfolio.  If you're about to yawn at the thought of a huge telecommunications company, stop -- and check out AT&T's (NYSE: T) recent dividend yield: 4.9%.  AT&T has recently sold off its 70% stake in DirecTV, generating a lot of cash that can be used to pay down debt and to reward shareholders.",
    "url": "https://finnhub.io/api/news?id=3c6ea6deb0a9a453672be2de0b036f2a665b44b868a0868d4d5ec85e674a2f52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735209300,
      "headline": "The Smartest Dividend Stocks to Buy With $1,000 Right Now",
      "id": 132164109,
      "image": "https://g.foolcdn.com/editorial/images/802040/getty-pointing-to-cash-fanned-out-in-hand.jpg",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Here are three dividend stocks to consider for your long-term portfolio.  If you're about to yawn at the thought of a huge telecommunications company, stop -- and check out AT&T's (NYSE: T) recent dividend yield: 4.9%.  AT&T has recently sold off its 70% stake in DirecTV, generating a lot of cash that can be used to pay down debt and to reward shareholders.",
      "url": "https://finnhub.io/api/news?id=3c6ea6deb0a9a453672be2de0b036f2a665b44b868a0868d4d5ec85e674a2f52"
    }
  },
  {
    "ts": null,
    "headline": "Kairos Pharma: Potential To Remove Resistance With Established Drugs",
    "summary": "Kairos Pharma's ENV-105 aims to overcome resistance in CRPC and EGFR-mutant NSCLC, with key data releases expected in 2025. Explore more details here.",
    "url": "https://finnhub.io/api/news?id=13dd7bdadce638afc2bf7f47929662c415e77bfac121dca7c36221645b5869fb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735199509,
      "headline": "Kairos Pharma: Potential To Remove Resistance With Established Drugs",
      "id": 132163701,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1386962383/image_1386962383.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Kairos Pharma's ENV-105 aims to overcome resistance in CRPC and EGFR-mutant NSCLC, with key data releases expected in 2025. Explore more details here.",
      "url": "https://finnhub.io/api/news?id=13dd7bdadce638afc2bf7f47929662c415e77bfac121dca7c36221645b5869fb"
    }
  }
]